Business Context and Reporting Period
Company: Kewaunee Scientific Corporation
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended July 31, 1995
Business Overview: Manufacturer of laboratory furniture. The company reported a net profit for the quarter, driven by significant reductions in operating expenses despite a decline in sales volume due to lower market demand.
Key Financial Metrics
| Metric ($ in thousands) | Q1 1996 (Ended July 31, 1995) | Q1 1995 (Ended July 31, 1994) |
|---|---|---|
| Net Sales | $15,548 | $16,383 |
| Gross Profit | $2,673 | $2,825 |
| Gross Margin | 17.2% | 17.2% |
| Operating Earnings | $258 | ($215) Loss |
| Net Earnings | $70 | ($111) Loss |
| Earnings Per Share | $0.03 | ($0.05) |
| Cash Used in Operating Activities | ($571) | ($627) |
| Working Capital | $7,345 | N/A |
| Debt-to-Equity Ratio | 0.44:1 | N/A |
Material Changes vs. Prior Period
- Sales Decline: Net sales decreased 5.1% to $15.5 million, attributed to lower market demand for laboratory furniture.
- Operating Expense Reduction: Operating expenses dropped 20.6% to $2.4 million (15.5% of sales vs. 18.6% prior year), primarily due to reductions in management and administrative personnel.
- Profitability Turnaround: The company moved from an operating loss of $215,000 to an operating profit of $258,000. Net income improved from a loss of $111,000 to a profit of $70,000.
- Interest Expense Increase: Interest expense rose to $204,000 from $85,000 due to higher debt levels and interest rates.
- Other Income Decrease: Other income fell to $16,000 from $161,000, as the prior year included a one-time cash settlement from a previously written-down investment.
- Inventory Buildup: Inventories increased by $449,000, contributing to cash outflows in operating activities.
Outlook, Risks, and Management Commentary
- Liquidity: Management believes current sources of liquidity (operations and short-term borrowings) are sufficient to support ongoing business, capital expenditures, and debt service. Working capital increased to $7.3 million.
- Credit Facilities: Unused credit available under the revolving credit facility decreased to $1.6 million from $2.1 million at the end of the prior fiscal year.
- Capital Expenditures: The company spent $166,000 on capital expenditures, primarily for production machinery, and does not anticipate abnormal levels of spending for the remainder of the fiscal year.
- Risks: The filing notes that results for interim periods are not necessarily indicative of full-year results. The company faces risks related to market demand fluctuations and interest rate sensitivity.
Investor Verification Checklist
- Verify the sustainability of the 20.6% reduction in operating expenses and whether further personnel cuts are planned.
- Confirm the trend in market demand for laboratory furniture to assess the risk of continued sales declines.
- Monitor the utilization of the revolving credit facility, which has decreased to $1.6 million in unused capacity.
- Review the impact of rising interest rates on future interest expense given the increased debt levels.
- Assess the necessity of the $449,000 inventory increase relative to current sales velocity.